B of A Securities Maintains Neutral on ProKidney, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has maintained a Neutral rating on ProKidney (NASDAQ:PROK) but has lowered its price target from $4 to $3.
September 04, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities has maintained a Neutral rating on ProKidney but reduced the price target from $4 to $3, indicating a less optimistic outlook.
The reduction in the price target from $4 to $3 by B of A Securities suggests a less optimistic view on ProKidney's future performance, which could lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100